US drug regulator USFDA has given 11 drops to Dr Reddys, the leading pharmaceutical company, for its formulation plants located in Hyderabad.
USFDA has issued comments after Dr Reddy’s inspection of this plant But the drug company has not provided the inspection date.
According to the rules, the company has been awarded Form 483 with 11 comments. Explain that the company receiving the comments from USFDA has to reply in writing in 15 days with
Due to this news, the shares of Dr. Reddy’s are under pressure today. In the BSE,
Get detailed equity Service provider right here at BSE & NSE. We provide Indian Stock market service like Equity Service, MCX, HNI& Currency Service | Ripples Advisory Private Limited